SPONSOR
Tor Biering-Sørensen
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Tor Biering-Sørensen is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Heart Failure With Preserved Ejection Fraction, Heart Failure.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tor Biering-Sørensen
How many clinical trials has Tor Biering-Sørensen sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Tor Biering-Sørensen, of which 2 are actively recruiting participants. These trials cover conditions including Heart Failure With Preserved Ejection Fraction, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tor Biering-Sørensen research focus on?
Tor Biering-Sørensen clinical trials span Heart Failure With Preserved Ejection Fraction, Heart Failure. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tor Biering-Sørensen clinical trial?
To participate in a Tor Biering-Sørensen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tor Biering-Sørensen trials with current recruitment status updated daily.
Clinical Trials by Tor Biering-Sørensen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology